Abcellera Biologics Inc
F:8QQ
Wall Street
Price Targets
8QQ Price Targets Summary
Abcellera Biologics Inc
According to Wall Street analysts, the average 1-year price target for
8QQ
is 8.9 EUR
with a low forecast of 6.27 EUR and a high forecast of 14.9 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 8QQ's stock price target?
Price Target
8.9
EUR
According to Wall Street analysts, the average 1-year price target for
8QQ
is 8.9 EUR
with a low forecast of 6.27 EUR and a high forecast of 14.9 EUR.
What is Abcellera Biologics Inc's Revenue forecast?
Projected CAGR
50%
For the last 5 years the
compound annual growth rate for
Abcellera Biologics Inc's revenue is
20%.
The projected
CAGR
for the next 4 years is
50%.